MENU
ONC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BeiGene (ONC) Ownership - Who owns BeiGene?
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
32.21B
P/E Ratio
N/A
Total Cash
2.63B
Projected Growth
N/A
Total Debt
1.08B
Revenue
3.81B
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
24.43
Total Debt/Equity
N/A
Revenue/Share
36.19 USD as % of share price
Fundamentals
ONC
Capitalization
32.2B
P/E Ratio
N/A
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
2.63B
Total Cash/Share
24.43
Total Debt
1.08B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
36.19%
Revenue
3.81B
ROE
N/A
Book Value
3.33B
P/B Ratio
8.75
Cash Flow
N/A
Earnings
-6.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
138K
Current Ratio
1.80
Current Revenue Per Employee
102529.45
Dividends Per Share - Security
N/A
EBITDA
-396.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.76
Revenue To Assets
-11.00
Shares Held By Institutions
23.5B
Shares Outstanding - Current
108M
Total Liabilities
2.59B
Total Volume MTD
N/A
Value
-1
Gain YTD
46.738
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A